USE OF LOW DOSE CHEMICALLY MODIFIED TETRACYCLINES TO REDUCE INFLAMMATORY MEDIATORS

摘要

The invention is a method for reducing the production of inflammatory mediators, and/or treating conditions characterized by increased levels of inflammatory mediators, in a mammal in need thereof, by administering a 4-dedimethlarninosancycline to the mammal.